Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 20, 2019 Off

VenatoRx Pharmaceuticals Founders Named Entrepreneur Of The Year 2019 Award Winners in Greater Philadelphia

By BusinessWire

MALVERN, Pa.–(BUSINESS WIRE)–#antibiotics—VenatoRx Pharmaceuticals today announced that its founders, Christopher J. Burns, Ph.D., Daniel C. Pevear, Ph.D., and Luigi Xerri,…

June 20, 2019 Off

Fresenius Kabi Introduces Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection

By BusinessWire

Generic equivalent to Precedex™ is latest addition to growing anesthesia and analgesia portfolio LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi announced today…

June 20, 2019 Off

Pear Therapeutics to Participate in the Oppenheimer Summit for Emerging Biotechnology

By BusinessWire

BOSTON–(BUSINESS WIRE)–Pear Therapeutics, Inc., the leader in prescription digital therapeutics (PDTs), today announced that Christopher D.T. Guiffre, J.D., M.B.A., Chief…

June 20, 2019 Off

Recursion Appoints Dr. Sharath Hegde as its Chief Scientific Officer

By BusinessWire

Dr. Hegde brings decades of experience discovering and developing new medicines to clinical-stage biotech at the forefront of applying artificial…

Axial Biotherapeutics bags  $10M Investment from Taiho Ventures to Access Axial’s Expertise in the Gut-Brain Axis
June 20, 2019 Off

Axial Biotherapeutics bags $10M Investment from Taiho Ventures to Access Axial’s Expertise in the Gut-Brain Axis

By BusinessWire

$10M investment as Series B extension, bringing total amount raised to $35M –

– Direct investment for the discovery of gut targeted, small molecule therapeutics in oncology utilizing Axial’s novel platform technology

Cancer Prevention Pharmaceuticals (CPP)  FAP Phase 3 Trial doesn’t show statistical significance in outperforming the single agents
June 20, 2019 Off

Cancer Prevention Pharmaceuticals (CPP) FAP Phase 3 Trial doesn’t show statistical significance in outperforming the single agents

By BusinessWire

The combination did not demonstrate statistical significance in outperforming the single agents in the overall population

June 20, 2019 Off

Vaxart to Present at ASM Microbe 2019

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Vaxart, Inc. (NASDAQ: VXRT), a clinical stage biotechnology company developing oral recombinant vaccines that are administered…

June 20, 2019 Off

Elligo Health Research Strengthens Ability to Grow and Enable Physician Practice Clinical Research

By BusinessWire

AUSTIN, Texas–(BUSINESS WIRE)–Elligo Health Research, a healthcare-enabling research organization, welcomes Brandon Cormier, Jody Casey, and Faith Holmes, MD, FAAFP, AAHPM,…

Cyxone starts in-human testing of its multiple sclerosis drug candidate
June 20, 2019 Off

Cyxone starts in-human testing of its multiple sclerosis drug candidate

By Dino Mustafić

Swedish biotech company focused on autoimmune diseases, Cyxone is testing its drug candidate T20K, its first-in-human, phase I, clinical trial, for the treatment of multiple sclerosis (MS).

June 20, 2019 Off

Globally Recognized Nephrologist Joins Dicerna™ to Support Continued Development of DCR-PHXC for the Treatment of Primary Hyperoxaluria

By BusinessWire

– Prof. Bernd Hoppe, M.D., Appointed Vice President, Global Medical Affairs at Dicerna – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dicerna™ Pharmaceuticals, Inc. (Nasdaq:…

Posts pagination

Previous 1 … 3,060 3,061 3,062 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine